← Back to the board
Issue file · proposed
Federal funding for novel antibiotics against drug-resistant bacteria (ASPR/BARDA antimicrobial resistance countermeasures)
Federal funding, contracting, and policy for development of new antibiotics against drug-resistant (e.g., gram-negative) bacteria, including HHS ASPR/BARDA awards to industry, Project BioShield and CARB-X-type support, market incentives such as the PASTEUR Act subscription model, and appropriations for antimicrobial resistance preparedness.
Biotech
- Earliest seen
- —
- No coverage yet
- Articles · 30d
- 0
- No coverage
- Outlets
- 0
- —
- Hill · 30d
- 0
- None in 30 days or ahead
- Contracts · 30d
- 0
- No awards or solicitations
- Momentum
- 0.0
- Articles ±0 vs prior week
Activity
30 days back, 14 ahead · hollow = scheduled- Total
- 0
- Peak/day
- 0
- 7d
- 0±0
- Next
- —
Σ/day0
Hill0
Contracts0
News0
What's happening
No summary yet: this issue is new.
Hill
No policymaker activity in the window.
Contracts
No procurement or funding activity in the window.
Pressure
No outside pressure in the window.
Who covered it, when
A dot per article · ringed = earliest in our sourcesNo coverage in the last 30 days.
In the news
0 articlesNo coverage yet.